Fatma Visal Okur

402 total citations
22 papers, 186 citations indexed

About

Fatma Visal Okur is a scholar working on Oncology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Fatma Visal Okur has authored 22 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Genetics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Fatma Visal Okur's work include Chronic Lymphocytic Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Fatma Visal Okur is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Fatma Visal Okur collaborates with scholars based in Türkiye, United States and Canada. Fatma Visal Okur's co-authors include Ceyda Karadeniz, Aynur Oğuz, Elvan Çağlar Çıtak, Malcolm K. Brenner, Duygu Uçkan, Barış Kuşkonmaz, Faruk Güçlü Pınarlı, Nalân Akyürek, Robert A. Krance and Çetin Kocaefe and has published in prestigious journals such as Blood, Molecular Cancer and Stem Cell Research & Therapy.

In The Last Decade

Fatma Visal Okur

20 papers receiving 182 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Fatma Visal Okur 61 60 55 45 29 22 186
Taizo A. Nakano 110 1.8× 38 0.6× 69 1.3× 58 1.3× 47 1.6× 30 246
Natasha Lewis 32 0.5× 84 1.4× 70 1.3× 28 0.6× 33 1.1× 20 195
Chetan Dhamne 46 0.8× 29 0.5× 101 1.8× 55 1.2× 49 1.7× 47 279
J. Gottlieb 49 0.8× 56 0.9× 90 1.6× 49 1.1× 34 1.2× 15 259
Frederique Bouwman 97 1.6× 29 0.5× 95 1.7× 15 0.3× 28 1.0× 14 293
Toshikazu Akioka 22 0.4× 91 1.5× 79 1.4× 99 2.2× 35 1.2× 34 264
Francesco Volzone 62 1.0× 140 2.3× 98 1.8× 44 1.0× 12 0.4× 17 260
Sophie X. Song 32 0.5× 57 0.9× 37 0.7× 48 1.1× 8 0.3× 19 174
Chikako Kiyotani 68 1.1× 26 0.4× 33 0.6× 21 0.5× 56 1.9× 43 246
Anne Lambilliote 109 1.8× 134 2.2× 91 1.7× 27 0.6× 16 0.6× 4 304

Countries citing papers authored by Fatma Visal Okur

Since Specialization
Citations

This map shows the geographic impact of Fatma Visal Okur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma Visal Okur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma Visal Okur more than expected).

Fields of papers citing papers by Fatma Visal Okur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatma Visal Okur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma Visal Okur. The network helps show where Fatma Visal Okur may publish in the future.

Co-authorship network of co-authors of Fatma Visal Okur

This figure shows the co-authorship network connecting the top 25 collaborators of Fatma Visal Okur. A scholar is included among the top collaborators of Fatma Visal Okur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatma Visal Okur. Fatma Visal Okur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yalçın, Nadir, et al.. (2025). Ciclosporin-related posterior reversible encephalopathy syndrome in a paediatric haematopoietic stem cell transplant recipient. European Journal of Hospital Pharmacy. ejhpharm–2025.
2.
Okur, Fatma Visal, Hülya Demır, Ayşe Metìn, et al.. (2025). Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients. Journal of Clinical Immunology. 45(1). 148–148.
3.
Gülhan, Bora, Fatma Visal Okur, Fatih Özaltın, et al.. (2024). Calcineurin inhibitor‐related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature. Pediatric Transplantation. 28(4). e14778–e14778. 2 indexed citations
4.
Gülhan, Bora, Barış Kuşkonmaz, Fatma Visal Okur, et al.. (2022). Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantation. Pediatric Nephrology. 38(2). 461–469. 6 indexed citations
5.
6.
Aytaç, Selin, Günay Balta, Barış Kuşkonmaz, et al.. (2021). Isolated CNS Hemophagocytic Lymphohistiocytosis in Children:What We Know, What We Don't Know ?. Blood. 138(Supplement 1). 4190–4190. 1 indexed citations
7.
Kuşkonmaz, Barış, et al.. (2020). Evaluation of Drug-Related Problems in a Pediatric Bone Marrow Transplantation Unit Identified by a Clinical Pharmacist in-training in a 7-Month Period. Clinical and Experimental Health Sciences. 10(1). 21–26. 1 indexed citations
8.
Okur, Fatma Visal, et al.. (2019). Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods. Stem Cell Research & Therapy. 10(1). 211–211. 12 indexed citations
9.
Kuşkonmaz, Barış, Deniz Çağdaş, Müge Gökçe, et al.. (2017). Hematopoietic stem cell transplantation in children with Griscelli syndrome: A single‐center experience. Pediatric Transplantation. 21(7). 13 indexed citations
10.
Okur, Fatma Visal, Eric Yvon, Ettore Biagi, et al.. (2011). Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia. Cytotherapy. 13(9). 1128–1139. 11 indexed citations
11.
Okur, Fatma Visal & Robert A. Krance. (2010). Stem Cell Transplantation in Childhood Non-Hodgkin’s Lymphomas. Current Hematologic Malignancy Reports. 5(4). 192–199. 3 indexed citations
12.
Okur, Fatma Visal & Malcolm K. Brenner. (2010). Cellular Immunotherapy of Cancer. Methods in molecular biology. 651. 319–345. 11 indexed citations
13.
Okur, Fatma Visal, Ceyda Karadeniz, Münevver Büyükpamukçu, et al.. (2010). Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma. Pediatric Blood & Cancer. 55(7). 1272–1277. 9 indexed citations
14.
Foster, Aaron E., Fatma Visal Okur, Ettore Biagi, et al.. (2009). Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression. Molecular Cancer. 8(1). 106–106. 4 indexed citations
15.
Brenner, Malcolm K. & Fatma Visal Okur. (2009). Overview of gene therapy clinical progress including cancer treatment with gene-modified T cells. Hematology. 2009(1). 675–681. 11 indexed citations
16.
Okur, Fatma Visal, Eric Yvon, Gianpietro Dotti, et al.. (2008). Vaccination Strategies for Patients with B-CLL.. Blood. 112(11). 2106–2106. 1 indexed citations
17.
Oğuz, Aynur, et al.. (2006). EVALUATION OF PERIPHERAL LYMPHADENOPATHY IN CHILDREN. Pediatric Hematology and Oncology. 23(7). 549–561. 54 indexed citations
18.
Okur, Fatma Visal, et al.. (2006). Malignant Triton Tumor of the Pelvis in a 2-year-old Boy. Journal of Pediatric Hematology/Oncology. 28(3). 173–176. 8 indexed citations
19.
Oğuz, Aynur, Ceyda Karadeniz, Fatma Visal Okur, et al.. (2005). Prognostic factors and treatment outcome in childhood hodgkin disease. Pediatric Blood & Cancer. 45(5). 670–675. 22 indexed citations
20.
Okur, Fatma Visal, et al.. (2005). REFRACTORINESS TO RITUXIMAB MONOTHERAPY IN A CHILD WITH RELAPSED/REFRACTORY BURKITT NON-HODGKIN LYMPHOMA. Pediatric Hematology and Oncology. 23(1). 25–31. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taizo A. Nakano Breakdown of academic impact, for papers by Natasha Lewis Breakdown of academic impact, for papers by Chetan Dhamne Breakdown of academic impact, for papers by J. Gottlieb Breakdown of academic impact, for papers by Frederique Bouwman Breakdown of academic impact, for papers by Toshikazu Akioka Breakdown of academic impact, for papers by Francesco Volzone Breakdown of academic impact, for papers by Sophie X. Song Breakdown of academic impact, for papers by Chikako Kiyotani Breakdown of academic impact, for papers by Anne Lambilliote
Rankless by CCL
2026